dc.contributor.author
Edemann-Callesen, Henriette
dc.contributor.author
Barak, Segev
dc.contributor.author
Hadar, Ravit
dc.contributor.author
Winter, Christine
dc.date.accessioned
2022-07-28T12:30:35Z
dc.date.available
2022-07-28T12:30:35Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/35681
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-35396
dc.description.abstract
Purpose of the Review: Development of addiction involves a transition from reward-driven to habitual behavior, mediated by neuroplastic changes. Based on preclinical findings, this article article reviews the current knowledge on the use of neuromodulation therapies to target alcohol addiction and essentially reduce relapse.
Recent Findings: To date, only a limited number of preclinical studies have investigated the use of neuromodulation in alcohol addiction, with the focus being on targeting the brain reward system. However, as addiction develops, additional circuits are recruited. Therefore, a differential setup may be required when seeking to alter the chronic alcohol-dependent brain, as opposed to treating earlier phases of alcohol addiction.
Summary: To promote enduring relapse prevention, the choice of brain target should match the stage of the disorder. Further studies are needed to investigate which brain areas should be targeted by neuromodulating strategies, in order to sufficiently alter the behavior and pathophysiology as alcohol addiction progresses.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Alcohol addiction
en
dc.subject
Neuromodulation
en
dc.subject
Neuroplastic changes
en
dc.subject
Neuronal circuits
en
dc.subject
Brain reward system
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Choosing the Optimal Brain Target for Neuromodulation Therapies as Alcohol Addiction Progresses—Insights From Pre-Clinical Studies
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s40429-020-00316-w
dcterms.bibliographicCitation.journaltitle
Current Addiction Reports
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
237
dcterms.bibliographicCitation.pageend
244
dcterms.bibliographicCitation.volume
7
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2196-2952